🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Þorvarður Jón Löve

Reykjavík University

ORCID: 0000-0002-2680-6120

Also affiliated with University of Iceland, National University Hospital of Iceland

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.8Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study

Lara D. Veeken(2021)10.1093/rheumatology/keab622
Top 12%
1.8DataRank
Top 12%49 citations

Daniel B. Shin, Þorvarður Jón Löve, Joel M. Gelfand, Alexis Ogdie

Papers

Driven by 5 papers — median percentile 88. Top paper: “Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study”.

Body surface area affected by psoriasis and the risk for psoriatic arthritis: a prospective population-based cohort study

Lara D. Veeken(2021)10.1093/rheumatology/keab622
Top 12%
1.8DataRank
Top 12%49 citations

Daniel B. Shin, Þorvarður Jón Löve, Joel M. Gelfand, Alexis Ogdie

Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry

Scandinavian Journal of Rheumatology(2024)10.1080/03009742.2024.2352967
N/A
0.292DataRank · unranked
6 citations

Þorvarður Jón Löve, Johan K. Wallman, Meliha C Kapetanovic, PS Gunnarsson, Björn Guðbjörnsson +1 more

Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden

Haematologica(2024)10.3324/haematol.2023.284365
N/A
0.104DataRank · unranked
1 citations

Sigrún Þorsteinsdóttir, Elisavet Syriopoulou, Ingigerður Sverrisdóttir, Ingemar Turesson, Elías Eyþórsson +20 more

Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies

The Journal of Rheumatology(2021)10.3899/jrheum.210006
N/A
0DataRank · unranked
43 citations

Telma Thrastardottir, Xingmei Wang, Maureen Dubreuil, Yong Chen, Joel M. Gelfand +3 more

Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study

Blood Cancer Journal(2021)10.1038/s41408-021-00580-7
N/A
0DataRank · unranked
11 citations

Elías Eyþórsson, Sigrún Þorsteinsdóttir, Brynjar Viðarsson, Páll T. Önundarson, Bjarni A. Agnarsson +24 more